Whalesbook
So, market mein aaj Rossari Biotech ke share mein thoda girawat dikhi hai, around 1.95% neeche jaakar ₹506.15 par close hua. Aisa isliye hua kyunki rumors hain ki company ke promoters apna kuch stake sell karne ke bare mein soch rahe hain. Aur company ka jo expansion plan hai, use thoda dheere-dheere karne ka decision bhi investors ko thoda uncomfortable kar raha hai.
Financials Toh Badhiya Hain!
Lekin numbers ki baat karein toh company ne Q4 FY26 ke liye zabardast results report kiye hain. Net profit year-on-year 33.43% badh kar ₹46 Crore ho gaya hai, jo pichle saal ₹34 Crore tha. Revenue bhi 18.2% jump kar ke ₹684.8 Crore pahunch gaya. EBITDA bhi 11% upar hai, ₹77.2 Crore, jo operational efficiency ko stable rakhta hai. Aur company ne 25% ka final dividend bhi announce kiya hai.
Valuation Aur Sector Ka Scene
Abhi company ka market cap lagbhag ₹2,800-2,850 Crore ke aas paas hai. Specialty chemicals sector ki baat karein toh Indian market mein ye sector 3.65% se 4.8% tak grow hone ka estimate hai 2033 tak. Rossari ka valuation baaki peers jaise Aarti Industries (~57.8x P/E) se toh kam hai, par sector ke average P/E (~34.23%) se compare karein toh theek hai.
Investor Kyon Chintit Hain?
Jo stake sale ki baat chal rahi hai, woh abhi early stage par hai aur non-binding hai, par koi bhi promoter exit future strategy ko lekar uncertainty laata hai. Expansion ko phased way mein karna, matlab naye facilities ko full capacity par lane mein do saal lag sakte hain, ye bhi slow growth dikha raha hai is high-growth sector mein. Is wajah se, institutions jaise SBI Mutual Fund ne bhi apni holding kam ki hai, unka stake 3% se neeche chala gaya hai April 2026 mein.
Analyst View Aur Future Plans
Lekin analysts abhi bhi optimistic hain. Inka consensus 'Strong Buy' rating hai aur target price ₹635-648 de rahe hain, matlab lagbhag 23% se zyada ka upside potential dikh raha hai. Company ne Navi Mumbai mein naya R&D facility bhi khola hai, aur Saudi Arabia mein bhi future mein manufacturing plans hain. Management innovation aur margin improve karne par focus kar raha hai.